Evidence map›Paper›PMID 40590229›Full record

ArticleThe Journal of clinical investigation2025

Mitofusin 2 controls mitochondrial and synaptic dynamics of suprachiasmatic VIP neurons and related circadian rhythms.

Milan Stoiljkovic, Jae Eun Song, Hee-Kyung Hong, Heiko Endle, Luis Varela, Jonatas Catarino, Xiao-Bing Gao, Zong-Wu Liu, Peter Sotonyi, Sabrina Diano and 3 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Hypothalamic regulation of energy homeostasis: Quo vadis.Reviews in endocrine & metabolic disorders · 2026
    Review
  2. Review
  3. Review
  4. Neurobiology of mitochondrial dynamics in sleep.The Journal of physiology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Milan StoiljkovicDepartment of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Jae Eun SongDepartment of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Hee-Kyung HongDepartment of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Heiko EndleDepartment of Molecular and Translational Neuroscience of Anatomy II, University of Cologne, Cologne, Germany.
Luis VarelaDepartment of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Jonatas CatarinoDepartment of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Xiao-Bing GaoDepartment of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Zong-Wu LiuDepartment of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Peter SotonyiDepartment of Anatomy and Histology, University of Veterinary Medicine, Budapest, Hungary.
Sabrina DianoDepartment of Physiology and Institute of Human Nutrition, Columbia University Irving Medical Center, New York, New York, USA.
Jonathan CedernaesDepartment of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Joseph BassDepartment of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Tamas L HorvathDepartment of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Funding

The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
Integration of Feeding Time and Glucose Metabolism by the Circadian Gene NetworkR01DK090625 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BASS, JOSEPH, LERNER, TALIA NEWCOMBE · 2011 to 2025
$6.9M
Hypothalamus-driven anti-aging processes impact murine models of Alzheimer's DiseaseR01AG067329 · NIA · YALE UNIVERSITY · PI HORVATH, TAMAS L · 2020 to 2024
$3.2M
Hypothalamic lipid signaling in metabolism regulationR01DK136079 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sabrina Diano · 2023 to 2026
$2.9M
Dorsal raphe nucleus melanocortin signaling regulates energy homeostasisR01DK131717 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DIANO, SABRINA · 2022 to 2025
$2.5M
Augmenting AXL and MERTK function to restrain cognitive decline and improve health span in mouse models of Alzheimer's DiseaseRF1AG082190 · NIA · YALE UNIVERSITY · PI GHOSH, SOURAV, GRUTZENDLER, JAIME · 2023 to 2023
$2.4M
Cross-regulation of Immunometabolism and Circadian Pathways in Obesity PathophysiologyR01DK127800 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BASS, JOSEPH · 2021 to 2025
$2.3M
The role of mitochondrial dynamics in diet-influenced regulation of food intake and adiposityR01DK126447 · NIDDK · YALE UNIVERSITY · PI HORVATH, TAMAS L, RODEHEFFER, MATTHEW S · 2021 to 2024
$2.3M
MCHergic control of feeding and energy balance in the LH areaR01DK120891 · NIDDK · YALE UNIVERSITY · PI GAO, XIAO-BING, HORVATH, TAMAS L · 2020 to 2023
$2.1M
Circadian SCN-Liver Axis in the Neuroendocrine Response to Calorie RestrictionR01DK132647 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Joseph Bass · 2023 to 2026
$2.1M
Bioenergetic Mechanisms Underlying Circadian Dietary InterventionR01AG065988 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BASS, JOSEPH · 2019 to 2023
$2.0M
Augmenting AXL and MERTK function to restrain cognitive decline and improve health span in mouse models of Alzheimer's DiseaseR01AG082190 · NIA · UNIVERSITY OF MINNESOTA · PI Sourav Ghosh, Jaime Grutzendler · 2026 to 2026
$707k
NIA NIH HHS P01 AG051459NIA NIH HHS R01 AG065988NIA NIH HHS R01 AG067329NIA NIH HHS R01 AG082190NIA NIH HHS RF1 AG082190NIDDK NIH HHS R01 DK090625NIDDK NIH HHS R01 DK120891NIDDK NIH HHS R01 DK126447NIDDK NIH HHS R01 DK127800NIDDK NIH HHS R01 DK131717NIDDK NIH HHS R01 DK132647NIDDK NIH HHS R01 DK136079
6 · The paper itself

Abstract

Sustaining the strong rhythmic interactions between cellular adaptations and environmental cues has been posited as essential for preserving the physiological and behavioral alignment of an organism to the proper phase of the daily light/dark (LD) cycle. Here, we demonstrate that mitochondria and synaptic input organization of suprachiasmatic (SCN) vasoactive intestinal peptide-expressing (VIP-expressing) neurons showed circadian rhythmicity. Perturbed mitochondrial dynamics achieved by conditional ablation of the fusogenic protein mitofusin 2 (Mfn2) in VIP neurons caused disrupted circadian oscillation in mitochondria and synapses in SCN VIP neurons, leading to desynchronization of entrainment to the LD cycle in Mfn2-deficient mice that resulted in an advanced phase angle of their locomotor activity onset, alterations in core body temperature, and sleep-wake amount and architecture. Our data provide direct evidence of circadian SCN clock machinery dependence on high-performance, Mfn2-regulated mitochondrial dynamics in VIP neurons for maintaining the coherence in daily biological rhythms of the mammalian organism.

Indexed as

Circadian RhythmGTP PhosphohydrolasesMitochondriaMitochondrial DynamicsMitochondrial ProteinsNeuronsSuprachiasmatic NucleusSuprachiasmatic Nucleus NeuronsSynapsesVasoactive Intestinal PeptideAnimalsMaleMiceMice, KnockoutGTP PhosphohydrolasesMfn2 protein, mouseMitochondrial ProteinsVasoactive Intestinal PeptideBehaviorCell biologyMetabolismMitochondriaNeuroscienceSynapses

Identifiers

PMID40590229
PMCPMC12208536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.